Literature DB >> 8323400

Beta 2 microglobulin measurements in saliva of patients with primary Sjögren's syndrome: influence of flow.

S A van der Geest1, H M Markusse, A J Swaak.   

Abstract

OBJECTIVES: To determine the diagnostic value of beta 2 microglobulin in parotid saliva, its concentration in relation to salivary flow was determined in 29 patients with primary Sjögren's syndrome and in 30 normal controls. The specific secretion rate of beta 2 microglobulin was calculated.
METHODS: Parotid saliva samples were collected within a 20 minute period directly from Stensen's duct with Lashley cups: sample 1 without gustatory stimulation during the first 10 minutes and samples 2 and 3 during the next five to 10 minutes, when saliva production was stimulated by a 500 mg vitamin C tablet. The sample volumes were measured and the beta 2 microglobulin concentration was determined by radioimmunoassay.
RESULTS: During gustatory stimulation the mean beta 2 microglobulin secretion rate in patients with primary Sjögren's syndrome was 0.31 microgram/min; in normal controls it was 0.14 microgram/min. The sensitivity and specificity of this test were 56 and 87% respectively. The mean salivary flow without stimulation in patients with primary Sjögren's syndrome was lower than that in normal controls, but no difference was found during stimulation.
CONCLUSIONS: Our results support the hypothesis of local beta 2 microglobulin production in the parotid gland of patients with primary Sjögren's syndrome. The test cannot be used as a screening test owing to low sensitivity, but it may be used as a supplementary diagnostic test as it has the advantage of being non-invasive.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8323400      PMCID: PMC1005073          DOI: 10.1136/ard.52.6.461

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

Review 1.  SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES.

Authors:  K J BLOCH; W W BUCHANAN; M J WOHL; J J BUNIM
Journal:  Medicine (Baltimore)       Date:  1965-05       Impact factor: 1.889

2.  Implications of a model from olfactory research for the use of secretion rates in salivary studies.

Authors:  J D Rudney
Journal:  Arch Oral Biol       Date:  1990       Impact factor: 2.633

3.  Diagnostic significance of salivary levels of beta 2-microglobulin in Sjögren's syndrome.

Authors:  A J Swaak; L L Visch; A Zonneveld
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

4.  Sjögren's syndrome. Proposed criteria for classification.

Authors:  R I Fox; C A Robinson; J G Curd; F Kozin; F V Howell
Journal:  Arthritis Rheum       Date:  1986-05

5.  Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids.

Authors:  I Berggård; A G Bearn
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

6.  Interaction of penicillin with HLA-A and -B antigens.

Authors:  F H Claas; R Runia-van Nieuwkoop; W van den Berge; J J van Rood
Journal:  Hum Immunol       Date:  1982-08       Impact factor: 2.850

Review 7.  Primary Sjogren syndrome: clinical and immunopathologic features.

Authors:  R I Fox; F V Howell; R C Bone; P Michelson
Journal:  Semin Arthritis Rheum       Date:  1984-11       Impact factor: 5.532

8.  Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane.

Authors:  P Cresswell; T Springer; J L Strominger; M J Turner; H M Grey; R T Kubo
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

9.  Sjögren's syndrome (Sicca syndrome): current issues.

Authors:  H M Moutsopoulos; T M Chused; D L Mann; J H Klippel; A S Fauci; M M Frank; T J Lawley; M I Hamburger
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

10.  Elevated salivary and synovial fluid beta2-microglobulin in Sjogren's syndrome and rheumatoid arthritis.

Authors:  N Talal; H M Grey; N Zvaifler; J P Michalski; T E Daniels
Journal:  Science       Date:  1975-03-28       Impact factor: 47.728

View more
  5 in total

1.  Low-level laser therapy for xerostomia in primary Sjögren's syndrome: a randomized trial.

Authors:  Tania Fidelix; Adriano Czapkowski; Sergio Azjen; Adagmar Andriolo; Pedro Horvath Neto; Virgínia Trevisani
Journal:  Clin Rheumatol       Date:  2017-11-09       Impact factor: 2.980

Review 2.  Salivary Biomarkers in Patients with Sjögren's Syndrome-A Systematic Review.

Authors:  Ju-Yang Jung; Ji-Won Kim; Hyoun-Ah Kim; Chang-Hee Suh
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

3.  Beta-2 Microglobulin in Whole Unstimulated Saliva Can Effectively Distinguish Between Sjögren's Syndrome and Non-Autoimmune Sicca Symptoms.

Authors:  Janett Riega-Torres; Guillermo Delgado-García; Julio César Salas-Alanís; Cassandra Skinner-Taylor; Lorena Pérez-Barbosa; Mario Garza-Elizondo; Celia Nohemí Sánchez-Domínguez; Luis Ángel Ceceñas-Falcón; Karim Mohamed-Noriega; Jesús Mohamed-Hamsho; David Vega-Morales
Journal:  Arch Rheumatol       Date:  2017-05-25       Impact factor: 1.472

4.  The Relationship between Salivary Beta-2 Microglobulin and Uremia Intensity in Men with Chronic Renal Failure.

Authors:  Mohammad Vahedi; Hossein Malekzadeh; Habib Haybar; Ali Reza Soltanian; Shermin Abdollahzadeh; Hojjat Yoosefi; Masoud Seyedian; Leila Yazdanpanah; Abrotan Saeid; Maryam Shabanpour Fooladi; Marziyeh Ghasemi
Journal:  Cell J       Date:  2013-02-20       Impact factor: 2.479

5.  Evaluation of salivary beta-2 microglobulin as HBV proliferation marker in HBS Ag(+), HBV DNA PCR(+) and HBV DNA PCR(-) subjects.

Authors:  Hamidreza Abdolsamadi; Peiman Eini; Negin Ronasi; Seyed Alireza Kaboli; Mehrdad Hajilooei; Abbas MoghimBeigi; Poorandokht Davoudi; Fatemeh AhmadiMotemayel; Hamid Mohaghegh Shalmani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.